SCHEMBL25817086

SCHEMBL25817086

O=CCC1C(=O)c2ccccc2C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.44
MEN1 O00255 6/20 0.44
S100A4 P26447 2/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 5/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 1/20 0.41
HTR2B P41595 1/20 0.41
PIM1 P11309 1/20 0.40
KDM4E B2RXH2 2/20 0.38
RAB9A P51151 3/20 0.36
NPC1 O15118 3/20 0.36
HBB P68871 2/20 0.36
ALOX15 P16050 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9547888 0.85 HTR2A (0.42) KMT2AMEN1S100A4POLBMAPT
SCHEMBL73177 0.77 HTR2A (0.52) KMT2APOLBCYP1A2HSD17B10
SCHEMBL86112 0.71 KMT2A (0.48) KMT2AMEN1S100A4POLBMAPT
SCHEMBL10287951 0.71 MEN1 (0.48) KMT2AMEN1S100A4POLBMAPT
SCHEMBL8365427 0.71 ALDH1A1 (0.58) KMT2AMEN1S100A4POLBMAPT
SCHEMBL23044111 0.70 LMNA (0.50) KMT2AMEN1S100A4POLBMAPT
SCHEMBL4563067 0.70 HSD17B10 (0.54) KMT2AMEN1S100A4POLBMAPT
Hydrochloric Acid SCHEMBL1372128 0.70 MAPT (0.47) KMT2AMEN1S100A4POLBMAPT
SCHEMBL8364658 0.69 METAP1 (0.61) HTR2B
SCHEMBL18328075 0.69 MEN1 (0.44) KMT2AMEN1S100A4POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ACUCELA INC. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230218549-A1 ALKOXY COMPOUNDS FOR DISEASE TREATMENT ALDH1A2, CLN6, AGER KMT2A 3008/4885MEN1 4640/4885S100A4 2725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.